The
global Ophthalmic Viscosurgical
Devices Market size is anticipated to reach USD 521.1 million by
2026, registering a CAGR of 7.9% over the forecast period, according to a new
report published by Grand View Research, Inc. Steady rise in geriatric
population coupled with high prevalence of ocular disorders is expected to
drive the growth. Constantly developing ophthalmic care facilities are expected
to contribute to the demand for Ophthalmic Viscosurgical Devices (OVDs) in near
future.
Increasing
prevalence of diabetes is expected to be a major factor boosting the market
growth. Patients with both type 1 and type 2 diabetes are prone to develop
cataract at some point in time. Currently, the surgical procedure is the only
treatment option for cataract, thereby driving the demand for ophthalmic
viscosurgical devices-an integral part of the cataract surgery. Furthermore,
the global burden of cataract can be subjected to the increasing Cataract
Surgical Rate (CSR) in countries, such as India, Japan, U.S., and several Western
European countries.
Favorable
government and non-government initiatives, such as ophthalmic screening
programs, state and national eye care schemes, ophthalmic training, and
education programs are expected to play a significant role in the ophthalmic viscosurgical
devices market growth. For instance, the World Diabetes Foundation conducts
training and development programs for ophthalmic HCP at primary care in regions
of underdeveloped economies, improving the reach and awareness of cataract
treatment procedures.
Developing
advanced viscoelastics such as super-cohesive and viscoadpative OVD suitable
for each stages of routine and complex ocular surgery is an emerging trend in
the market. For instance, the viscoadpative OVDs have the combined benefit of cohesive
and dispersive OVDs contained in a single syringe suitable for complex cataract
surgery and ocular trauma cases.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/ophthalmic-viscosurgical-devices-market
https://www.grandviewresearch.com/industry-analysis/ophthalmic-viscosurgical-devices-market
Further key findings from the report suggest:
- Based on the
type, as cohesive and dispersive OVDs are used concomitantly in ocular
surgical procedures they together held significant share in the market. In
addition, the viscoadaptive OVDs segment is expected to register a healthy
CAGR over the forecast period, attributed to factors such as improved
surgical outcomes on usage of viscoadpative OVD coupled with increasing
number of complex ocular procedures
- Based on
application, the cataract surgery segment held the largest market share in
2018 and is expected to grow at significant rate over the forecast period.
Rising prevalence of diabetes, expanding geriatric population, favorable
eye care policies are some the factors expected to fuel the growth.
Expanding OVDs application into ocular surgeries such as glaucoma and
vitrectomy surgery are expected to witness growth, driving the market
growth
- North
America held the largest ophthalmic viscosurgical devices market share in
2018. Asia pacific is expected to expand at a speediest CAGR over the
forecast period due to the improving access to ophthalmic care facilities
and presence of large patient pool
- Viscoelastics
derived from synthetic sources is expected to grow at lucrative rate over
the forecast period. This can be attributed to its low purification cost,
high percentage of yield and easy extraction process compared to
viscoelastic from animal source. The emerging trend is genetically
engineering host bacteria to produce viscoelastic with low level of
endotoxins thereby enhanced purity
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment